Nova Labs Tesamorelin (2mg)

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), investigated for its role in stimulating endogenous growth hormone release via pituitary signalling pathways. It is studied in both clinical and experimental settings for its interaction with growth hormone and insulin-like growth factor-1 (IGF-1) pathways.

Tesamorelin has been explored in metabolic research contexts, including studies involving adipose tissue regulation and endocrine function.

Key Features:

• 2mg Tesamorelin per vial

• GHRH analogue involved in endogenous growth hormone signalling

• Investigated for interaction with GH and IGF-1 regulatory pathways

• Studied in relation to metabolic and endocrine processes

• Associated in research with adipose tissue and metabolic regulation pathways

• Commonly included in metabolic and longevity-focused research settings

Suggested Use:
For use under the guidance of a qualified professional. Protocols vary depending on application and individual requirements.

Storage:

• Lyophilized (unreconstituted): Store in a cool, dry place (15–25°C), protected from light

• After reconstitution: Store at 2–8°C. Do not freeze. Use within a limited timeframe

Important Information:
Tesamorelin has been studied in clinical settings for specific indications; however, this product should be used within appropriate regulatory and professional frameworks. Not recommended for individuals under 18, pregnant or breastfeeding individuals, or those with certain medical conditions. Ensure compliance with applicable regulations prior to use.